Metropolitan Life Insurance Company (MetLife)’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-254	Closed	-$101K	–	2644
2019 Q2	$101K	Hold	254	–	–	﹤0.01%	2298
2019 Q1	$119K	Hold	254	–	–	﹤0.01%	2221
2018 Q4	$122K	Hold	254	–	–	﹤0.01%	2140
2018 Q3	$173K	Buy	+254	New	+$163K	﹤0.01%	2100

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ELOX Position: Q3 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2019, closing a stake of 254 shares — an estimated $101K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ELOX in Q3 2018 and held it in 4 quarters. The position peaked at $173K in Q3 2018. 48 funds tracked by Wall St. Rank hold ELOX as of Q3 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 254 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $101K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $173K in Q3 2018.
48 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2019, filed 14 Nov 2019.